Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/29545714 below:

Cancer incidence and mortality in China, 2014

Affiliations

• ¹ National Office for Cancer Prevention and Control, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

• PMID: 29545714
• PMCID: PMC5842223
• DOI: 10.21147/j.issn.1000-9604.2018.01.01

Item in Clipboard

Wanqing Chen et al. Chin J Cancer Res. 2018 Feb.

• ¹ National Office for Cancer Prevention and Control, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

• PMID: 29545714
• PMCID: PMC5842223
• DOI: 10.21147/j.issn.1000-9604.2018.01.01

Item in Clipboard

Background: National Central Cancer Registry of China (NCCRC) updated nationwide cancer statistics using population-based cancer registry data in 2014 collected from all available cancer registries.

Methods: In 2017, 449 cancer registries submitted cancer registry data in 2014, among which 339 registries' data met the criteria of quality control and were included in analysis. These cancer registries covered 288,243,347 population, accounting for about 21.07% of the national population in 2014. Numbers of nationwide new cancer cases and deaths were estimated using calculated incidence and mortality rates and corresponding national population stratified by area, sex, age group and cancer type. The world Segi's population was applied for age-standardized rates.

Results: A total of 3,804,000 new cancer cases were diagnosed, the crude incidence rate was 278.07/100,000 (301.67/100,000 in males, 253.29/100,000 in females) and the age-standardized incidence rate by world standard population (ASIRW) was 186.53/100,000. Calculated age-standardized incidence rate was higher in urban areas than in rural areas (191.6/100,000 vs. 179.2/100,000). South China had the highest cancer incidence rate while Southwest China had the lowest incidence rate. Cancer incidence rate was higher in female for population between 20 to 54 years but was higher in male for population younger than 20 years or over 54 years. A total of 2,296,000 cancer deaths were reported, the crude mortality rate was 167.89/100,000 (207.24/100,000 in males, 126.54/100,000 in females) and the age-standardized mortality rate by world standard population (ASMRW) was 106.09/100,000. Calculated age-standardized mortality rate was higher in rural areas than in urban areas (110.3/100,000 vs. 102.5/100,000). East China had the highest cancer mortality rate while North China had the lowest mortality rate. The mortality rate in male was higher than that in female. Common cancer types and major causes of cancer death differed between age group and sex.

Conclusions: Heavy cancer burden and its disparities between area, sex and age group pose a major challenge to public health in China. Nationwide cancer registry plays a crucial role in cancer prevention and control.

Keywords: Cancer registry; China; epidemiology; incidence; mortality.

PubMed Disclaimer

Map of 339 contributing cancer registries…

Map of 339 contributing cancer registries and geographic regions in China (the dots are…

Map of 339 contributing cancer registries and geographic regions in China (the dots are locations of the cancer registries).

Age-specific cancer incidence and mortality by…

Age-specific cancer incidence and mortality by sex in China, 2014. (A) Age-specific cancer incidence…

Age-specific cancer incidence and mortality by sex in China, 2014. (A) Age-specific cancer incidence rates and new cases by sex; (B) Age-specific cancer mortality rates and deaths by sex.

• Cancer incidence and mortality in China, 2015.

  Zhang S, Sun K, Zheng R, Zeng H, Wang S, Chen R, Wei W, He J. Zhang S, et al. J Natl Cancer Cent. 2020 Dec 17;1(1):2-11. doi: 10.1016/j.jncc.2020.12.001. eCollection 2021 Mar. J Natl Cancer Cent. 2020. PMID: 39036787 Free PMC article.

• National cancer incidence and mortality in China, 2012.

  Chen W, Zheng R, Zuo T, Zeng H, Zhang S, He J. Chen W, et al. Chin J Cancer Res. 2016 Feb;28(1):1-11. doi: 10.3978/j.issn.1000-9604.2016.02.08. Chin J Cancer Res. 2016. PMID: 27041922 Free PMC article.

• [The incidence and mortality of lung cancer in China, 2014].

  Sun KX, Zheng RS, Zeng HM, Zhang SW, Zou XN, Gu XY, Xia CF, Yang ZX, Li H, Chen WQ, He J. Sun KX, et al. Zhonghua Zhong Liu Za Zhi. 2018 Nov 23;40(11):805-811. doi: 10.3760/cma.j.issn.0253-3766.2018.11.002. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30481929 Chinese.

• Report of incidence and mortality in China cancer registries, 2009.

  Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, He J. Chen W, et al. Chin J Cancer Res. 2013 Feb;25(1):10-21. doi: 10.3978/j.issn.1000-9604.2012.12.04. Chin J Cancer Res. 2013. PMID: 23372337 Free PMC article.

• Cancer incidence and mortality in Henan province, 2012.

  Liu S, Chen Q, Quan P, Zhang M, Zhang S, Guo L, Sun X, Wang C. Liu S, et al. Chin J Cancer Res. 2016 Jun;28(3):275-85. doi: 10.21147/j.issn.1000-9604.2016.03.02. Chin J Cancer Res. 2016. PMID: 27478313 Free PMC article.

• SOX2 amplification and chromosome 3 gain significantly impact prognosis in esophageal squamous cell carcinoma.

  Wang X, Ge X, Wang H, Huang J, Song Q, Xu C, Jiang Z, Su J, Wang H, Tan L, Jiang D, Hou Y. Wang X, et al. Ann Transl Med. 2021 Feb;9(4):321. doi: 10.21037/atm-20-1290. Ann Transl Med. 2021. PMID: 33708948 Free PMC article.

• Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection.

  Zhao G, Liu X, Liu Y, Li H, Ma Y, Li S, Zhu Y, Miao J, Xiong S, Fei S, Zheng M. Zhao G, et al. Front Genet. 2020 Jun 18;11:643. doi: 10.3389/fgene.2020.00643. eCollection 2020. Front Genet. 2020. PMID: 32625237 Free PMC article.

• TNF‑α promotes the malignant transformation of intestinal stem cells through the NF‑κB and Wnt/β‑catenin signaling pathways.

  Zhao X, Ma L, Dai L, Zuo D, Li X, Zhu H, Xu F. Zhao X, et al. Oncol Rep. 2020 Aug;44(2):577-588. doi: 10.3892/or.2020.7631. Epub 2020 Jun 4. Oncol Rep. 2020. PMID: 32627006 Free PMC article.

• Intratreatment Tumor Volume Change During Definitive Chemoradiotherapy is Predictive for Treatment Outcome of Patients with Esophageal Carcinoma.

  Huang R, Guo H, Chen J, Zhai T, Chen J, Lin K, Chen Z, Li D, Chen C. Huang R, et al. Cancer Manag Res. 2020 Aug 18;12:7331-7339. doi: 10.2147/CMAR.S246500. eCollection 2020. Cancer Manag Res. 2020. PMID: 32884347 Free PMC article.

• Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.

  Wang D, Liu Q, Ren Y, Zhang Y, Wang X, Liu B. Wang D, et al. Biosci Rep. 2021 Apr 30;41(4):BSR20204136. doi: 10.1042/BSR20204136. Biosci Rep. 2021. PMID: 33825830 Free PMC article.

1. 1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi: 10.3322/caac.21262. - DOI - PubMed
2. 1. Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Let. 2017;401:63–71. doi: 10.1016/j.canlet.2017.04.024. - DOI - PubMed

3. 1. National Cancer Center. Chinese Guideline for Cancer Registration. Beijing: People’s Medical Publishing House, 2016.

4. 1. Curade MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Volume IX. IARC Sci Publ 2008:1-837.

5. 1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86. doi: 10.1002/ijc.29210. - DOI - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3